MX361456B - Uso de una fuente de l3 y/o l5 como vacuna o como diagnostico para una enfermedad parasitaria. - Google Patents

Uso de una fuente de l3 y/o l5 como vacuna o como diagnostico para una enfermedad parasitaria.

Info

Publication number
MX361456B
MX361456B MX2016010072A MX2016010072A MX361456B MX 361456 B MX361456 B MX 361456B MX 2016010072 A MX2016010072 A MX 2016010072A MX 2016010072 A MX2016010072 A MX 2016010072A MX 361456 B MX361456 B MX 361456B
Authority
MX
Mexico
Prior art keywords
source
parasitic disease
diagnostic
vaccine
parasitic
Prior art date
Application number
MX2016010072A
Other languages
English (en)
Inventor
Bedate Alonso Carlos
Soto Álvarez Manuel
Ramírez García Laura
Original Assignee
Laboratorios Leti S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Leti S L filed Critical Laboratorios Leti S L
Priority claimed from PCT/EP2010/067380 external-priority patent/WO2011058137A1/en
Publication of MX361456B publication Critical patent/MX361456B/es

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente invención se refiere a composición que comprende una fuente de L3 y/o L5 y opcionalmente un adyuvante para la preparación de una medicina para el tratamiento o prevención de una enfermedad parasitaria y su uso en el diagnóstico de dicha enfermedad parasitaria.
MX2016010072A 2009-11-13 2010-11-12 Uso de una fuente de l3 y/o l5 como vacuna o como diagnostico para una enfermedad parasitaria. MX361456B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26102009P 2009-11-13 2009-11-13
EP09175929 2009-11-13
PCT/EP2010/067380 WO2011058137A1 (en) 2009-11-13 2010-11-12 The use of an l3 and/or l5 source as a vaccine or as a diagnostic for a parasitic disease

Publications (1)

Publication Number Publication Date
MX361456B true MX361456B (es) 2018-12-06

Family

ID=65681205

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016010072A MX361456B (es) 2009-11-13 2010-11-12 Uso de una fuente de l3 y/o l5 como vacuna o como diagnostico para una enfermedad parasitaria.

Country Status (2)

Country Link
CL (1) CL2012001249A1 (es)
MX (1) MX361456B (es)

Also Published As

Publication number Publication date
CL2012001249A1 (es) 2012-08-10

Similar Documents

Publication Publication Date Title
IN2012DN02736A (es)
MX2018009945A (es) Composiciones y metodos novedosos para el tratamiento de las enfermedades relacionadas con la inmunidad.
PH12015501637A1 (en) Inactivated dengue virus vaccine with aluminium-free adjuvant
MX347471B (es) Vacunas que comprenden colesterol y cpg como moleculas portadoras-adyuvantes unicas.
HK1163500A1 (en) Pharmaceutical composition for the treatment of heart diseases
SG178954A1 (en) Immunogenic compositions including tlr activity modulators
UA110473C2 (uk) Спосіб лікування раку за допомогою пухлиноасоційованого антигену, отриманого із цикліну d1
MX2013004817A (es) Enfermedad inflamatoria.
MX347734B (es) Anticuerpos anti-s100a4 y usos aplicaciones terapéuticas.
UA109661C2 (uk) Фармацевтична композиція співкристалів трамадолу і коксибів
GB2483419B (en) Formulations for the treatment of deep tissue pain
SG179082A1 (en) Method for the preparation of an influenza virus
WO2010135521A3 (en) Compositions and methods for the therapy and diagnosis of influenza
HRP20170176T1 (hr) Uporaba i3 i/ili l5 izvora kao cjepiva ili kao dijagnostičkog sredstva za parazitarnu bolest
MX2013010367A (es) Composiciones y metodos para la terapia y diagnostico de influenza.
MX361456B (es) Uso de una fuente de l3 y/o l5 como vacuna o como diagnostico para una enfermedad parasitaria.
TN2010000338A1 (en) Vaccine comprising a ribosomal protein extract (rpe) and optionally a th1-promoting adjuvant
WO2013093629A3 (en) Modular vaccines, methods and compositions related thereto
WO2011002423A3 (en) Solubility enhancing pharmaceutical composition